A next-generation dual guide CRISPR system for genetic interaction library screening

Thomas Burgold1, Emre Karakoc1,2, Emanuel Gonçalves1,3,4

  • 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Nature Communications
|December 6, 2025
PubMed

Insights

We developed a new CRISPR/Cas9 system for efficient screening of gene interactions. This method simplifies cloning and improves dual guide RNA expression, enabling large-scale genetic interaction studies for cancer therapy development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • CRISPR/Cas9 enables gene function perturbation for genetic interaction screening.
  • Existing dual guide RNA systems face challenges in cloning, guide pair purity, and expression balance.

Purpose of the Study:

  • To develop an improved system for dual guide RNA delivery for large-scale CRISPR/Cas9 genetic screens.
  • To overcome limitations of current dual guide expression systems.

Main Methods:

  • A novel dual guide RNA delivery system utilizing tRNA spacers for single-step cloning.
  • Implementation with Streptococcus pyogenes Cas9 (SpCas9) for library-scale screening.
  • Screening of a 100,136 guide pair library in colorectal cancer cells.

Main Results:

  • The new system allows for a single-step cloning strategy with minimal undesired guide pairs (as low as 2%).
  • Achieved highly balanced expression of the two delivered guide RNAs.
  • Successfully identified synthetic lethal genetic interactions in colorectal cancer cells.

Conclusions:

  • This next-generation system facilitates efficient and large-scale genetic interaction screening.
  • The versatile system can be adapted for various CRISPR applications, including combination therapy identification.
  • Demonstrates a robust method for discovering gene interactions relevant to cancer research.